Answers are grounded in this paper and cite their sources.
OmpA Ab is a conserved, abundantly expressed outer membrane porin in Acinetobacter baumannii whose presumed role in antibiotic permeation has not been clearly demonstrated. In this report, we use a titratable heterologous expression system to express OmpA Ab in isolation and demonstrate selective passage of small molecule antibiotics through OmpA Ab . ETX2514, a recently discovered broad-spectrum β-lactamase inhibitor, in combination with sulbactam, is currently in clinical testing for the treatment of drug-resistant A. baumannii infections. We demonstrate that ETX2514 permeates OmpA Ab and potentiates the activity of sulbactam in an OmpA Ab -dependent manner. In addition, we show that small modifications in the structure of ETX2514 differentially affect its passage through OmpA Ab, revealing unique structure-porin-permeation relationships. Finally, we confirm the contribution of OmpA Ab to bacterial fitness using a murine thigh model of A. baumannii infection. These results, combined with the high sequence homology of OmpA across Acinetobacter spp., suggest that optimization of antibiotic entry through OmpA Ab may prove to be a feasible medicinal chemistry design strategy for future antibacterial discovery efforts.
No takes yet. Share an insight, caveat, or question.
Iyer et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: